Prospera Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.2M Buy
96,118
+2,877
+3% +$619K 0.35% 55
2026
Q1
$20.3M Buy
93,241
+3,306
+4% +$733K 0.33% 58
2025
Q4
$20.6M Sell
89,935
-3,489
-4% -$795K 0.34% 60
2025
Q3
$21.6M Buy
93,424
+4,238
+5% +$863K 0.37% 51
2025
Q2
$16.6M Sell
89,186
-1,496
-2% -$278K 0.31% 68
2025
Q1
$19M Buy
90,682
+12,039
+15% +$2.34M 0.44% 51
2024
Q4
$14M Buy
78,643
+6,089
+8% +$1.12M 0.33% 67
2024
Q3
$14.3M Buy
72,554
+706
+1% +$132K 0.37% 61
2024
Q2
$12.3M Buy
71,848
+5,062
+8% +$839K 0.34% 63
2024
Q1
$12.2M Buy
66,786
+6,822
+11% +$1.18M 0.36% 54
2023
Q4
$9.29M Buy
59,964
+3,077
+5% +$449K 0.31% 68
2023
Q3
$8.49M Buy
56,887
+159
+0.3% +$23.3K 0.33% 64
2023
Q2
$7.65M Buy
56,728
+8,632
+18% +$1.27M 0.29% 76
2023
Q1
$7.67M Buy
48,096
+1,476
+3% +$226K 0.32% 67
2022
Q4
$7.53M Buy
46,620
+9,622
+26% +$1.48M 0.38% 61
2022
Q3
$4.97M Buy
36,998
+7,553
+26% +$1.08M 0.26% 90
2022
Q2
$4.51M Sell
29,445
-1,832
-6% -$280K 0.23% 96
2022
Q1
$5.08M Sell
31,277
-60,198
-66% -$8.74M 0.21% 106
2021
Q4
$12.4M Buy
91,475
+4,510
+5% +$533K 0.54% 20
2021
Q3
$9.38M Buy
86,965
+5,477
+7% +$626K 0.47% 26
2021
Q2
$9.18M Buy
81,488
+55,461
+213% +$6.25M 0.46% 29
2021
Q1
$2.82M Buy
26,027
+1,999
+8% +$214K 0.17% 153
2020
Q4
$2.58M Buy
24,028
+23,850
+13,399% +$2.29M 0.18% 141
2020
Q3
$16K Sell
178
-26,385
-99% -$2.48M 0.01% 958
2020
Q2
$2.6M Buy
26,563
+4,710
+22% +$415K 0.23% 108
2020
Q1
$1.67M Buy
21,853
+392
+2% +$33.4K 0.18% 141
2019
Q4
$1.9M Buy
21,461
+1,493
+7% +$124K 0.15% 177
2019
Q3
$1.51M Buy
19,968
+4,422
+28% +$303K 0.16% 140
2019
Q2
$1.13M Sell
15,546
-2,047
-12% -$161K 0.13% 151
2019
Q1
$1.48M Buy
17,593
+3,401
+24% +$278K 0.49% 60
2018
Q4
$1.3M Sell
14,192
-19,689
-58% -$1.73M 0.26% 91
2018
Q3
$3.17M Sell
33,881
-42,842
-56% -$4.06M 0.59% 22
2018
Q2
$7.2M Sell
76,723
-1,290
-2% -$126K 0.98% 12
2018
Q1
$7.3M Sell
78,013
-8,543
-10% -$938K 1.02% 11
2017
Q4
$8.52M Sell
86,556
-4,819
-5% -$454K 1.3% 9
2017
Q3
$8.19M Sell
91,375
-39
-0% -$2.97K 1.25% 9
2017
Q2
$6.58M Buy
91,414
+23,637
+35% +$1.59M 1.06% 10
2017
Q1
$4.41M Buy
67,777
+51,057
+305% +$3.21M 0.79% 15
2016
Q4
$1.06M Buy
16,720
+16
+0.1% +$977 0.21% 92
2016
Q3
$1.05M Sell
16,704
-1,913
-10% -$124K 0.21% 92
2016
Q2
$1.15M Sell
18,617
-2,309
-11% -$141K 0.24% 82
2016
Q1
$1.2M Buy
20,926
+3,222
+18% +$180K 0.27% 68
2015
Q4
$1.05M Buy
17,704
+4,475
+34% +$258K 0.23% 69
2015
Q3
$698K Buy
13,229
+767
+6% +$49.9K 0.18% 83
2015
Q2
$811K Sell
12,462
-463
-4% -$30.2K 0.19% 89
2015
Q1
$733K Buy
12,925
+4,970
+62% +$300K 0.16% 92
2014
Q4
$521K Sell
7,955
-1,616
-17% -$102K 0.13% 127
2014
Q3
$530K Buy
9,571
+1,308
+16% +$72.6K 0.14% 119
2014
Q2
$466K Buy
8,263
+34
+0.4% +$1.78K 0.13% 131
2014
Q1
$402K Buy
8,229
+3,769
+85% +$190K 0.13% 124
2013
Q4
$236K Sell
4,460
-10
-0.2% -$491 0.08% 202
2013
Q3
$205K Buy
+4,470
New +$198K 0.08% 208

Other funds holding ABBV

Prospera Financial Services's ABBV Position: Q2 2026 in Review

Prospera Financial Services increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $619K and bringing the position to 96,118 shares worth $24.2M. The position accounts for 0.35% of the portfolio, ranked #55.

Prospera Financial Services first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. 1,168 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prospera Financial Services held 96,118 shares of AbbVie worth $24.2M as of Q2 2026.
  • Prospera Financial Services bought 2,877 AbbVie shares in Q2 2026, an estimated $619K.
  • AbbVie made up 0.35% of Prospera Financial Services's portfolio in Q2 2026, its #55 holding.
  • Prospera Financial Services first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
  • 1,168 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.